NCT02170740View on ClinicalTrials.gov

Assessment of Safety, Pharmacokinetics and the Effect of BIBR 1048 MS on Coagulation Parameters in Healthy Volunteer Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 30, 1999

Primary Completion Date

January 31, 2000

Conditions
Healthy
Interventions
DRUG

BIBR 1048 MS - low dose

DRUG

BIBR 1048 MS - high dose

DRUG

BIBR 1048 MS + Pantoprazole

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY